Itulazax, Lyophilisat zum Einnehmen

7680672750019 CH-67275 Lyophilisat

Associated product:

ITULAZAX lyophilisat oral 12 SQ-Bet 30 pce
Itulazax, Lyophilisat zum Einnehmen
Itulazax, Lyophilisat zum Einnehmen
Itulazax, Lyophilisat zum Einnehmen
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Einzeldose(n)
Galenic form
Lyophilisat
Galenic group
Lösbar zur Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/09/2025
Patient information leaflet
Français
13/09/2025
Patient information leaflet
Italien
13/09/2025
Summary of Product Characteristics
Allemand
13/09/2025
Summary of Product Characteristics
Français
13/09/2025
Summary of Product Characteristics
Italien
13/09/2025

Detailed composition

Substance Quantity Type Category
PRC
12.0 U Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
0.49 MG Substance HBESI

Reimbursement information

Public price
CHF 133.00
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2020

Authorization holder

ALK-Abelló AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
67275
Drug name
Itulazax, Lyophilisat zur sublingualen Anwendung
Galenic form
LYSUV
ATC Code
V01AA05
Authorization status
Z
Dispensing category
A
First authorization
19/05/2020
Authorization expiration date
31/12/9999
IT Number
07.13.3.
Domain
Human medicine
Field of application
allergische Rhinitis und/oder Konjunktivitis

Package details

Description (FR)
ITULAZAX lyophilisat oral 12 SQ-Bet 30 pce
Description (DE)
ITULAZAX Lyophilisat oral 12 SQ-Bet 30 Stk
Market launch
19/05/2020
Narcotic (BTM)
No

Other package sizes (1)

ITULAZAX lyophilisat oral 12 SQ-Bet 90 pce
90 EINZ
GTIN: 7680672750026
View